CCR8 and neoplasm: Flow cytometry analysis further confirmed that CCR8+ Tregs highly express FOXP3 and CD25, along with immunosuppressive molecules such as CTLA4 and CD39, supporting their role as strongly suppressive tumor-localized Tregs.